Rift Valley Fever (RVF) Treatment Market Players:
- Novartis AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Sanofi-aventis Groupe
- Abbott Laboratories
- Merck & Co., Inc.,
- Siemens Healthcare GmbH
- Pfizer Inc.
- Eli Lilly and Company
- Cipla Limited
- Kemwell Biopharma Private Limited
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of rift valley fever treatment is evaluated at USD 2.16 billion.
The global rift valley fever treatment market size was worth over USD 2.06 billion in 2025 and is poised to grow at a CAGR of around 5.3%, reaching USD 3.45 billion revenue by 2035.
North America industry is expected to dominate majority revenue share of 35% by 2035.
Key players in the market include Abbott Laboratories, Merck & Co., Inc., Siemens Healthcare GmbH, Pfizer Inc., Eli Lilly and Company.
